Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Ophthalmology Contract Research Organization (CRO) Market

Ophthalmology Contract Research Organization (CRO) Market Share

Report ID: GMI6617
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Ophthalmology Contract Research Organization (CRO) Market Share

Major industry players operating in the ophthalmology contract research organization (CRO) market include

Charles River Laboratories International, Inc.
ICON plc Laboratory Corporation of America Holdings (Covance Inc.)
Medpace, Inc.
Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.)
Syneos Health
Worldwide Clinical Trials
WuXi AppTec
ORA Inc.
CTRG (Clinical Trial Resource Group)
Iris Pharma
Trial Runners
The Emmes Company LLC
Lexitas Pharma Services, Inc.
ProTrial Research, Inc.
TFS HealthScience

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ophthalmology contract research organization (CRO) market size reached USD 2.2 billion in 2022 and will record USD 4.4 billion by 2032 due to the surging prevalence of eye diseases coupled with rising demand for ophthalmic treatment.

Ophthalmology contract research organization market size from pharmaceutical and biopharmaceutical companies exceeded USD 1.2 billion in 2022 owing to increasing investment for the development of novel ophthalmology therapies and drugs.

North America held 39.6% share of the ophthalmology contract research organization industry in 2022 on account of the rising R&D investments and high number of ophthalmology clinical trials in the region.

ICON plc Laboratory Corporation of America Holdings (Covance Inc.), Medpace, Inc., Pharmaceutical Product Development (Thermo Fisher Scientific, Inc.), Syneos Health, and Worldwide Clinical Trials are some of the major industry players.